CABR Stock Analysis: Buy, Sell, or Hold?
$0.93
-0.01 (-0.82%)
▼
5d:
-17.31%
30d:
-20.81%
90d:
+6.9%
WAIT
LOW Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Get Alerted When CABR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CABR is down 17.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CABR is down 17.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CABR is currently trading at $0.93, which is considered oversold relative to its 30-day fair value range of $1.04 to $1.20.
Technical Outlook: Technically, CABR is in a uptrend. Immediate support is located at $0.90, while resistance sits at $1.23.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CABR is in a uptrend. Immediate support is located at $0.90, while resistance sits at $1.23.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.04 -
$1.20
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- WARNING: Recommendation downgraded due to -17.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.04 -
$1.20
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.90
Resistance Level
$1.23
Current Trend
Uptrend
Technical data as of
May 7, 2026
Fundamental Context
Revenue Growth (YoY)
-9.7%
Share & Embed Analysis
Last updated: May 08, 2026 8:18 AM ET
Data refreshes hourly during market hours. Next update: 9:18 AM
Data refreshes hourly during market hours. Next update: 9:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABR showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$186 | 63 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$96 | 66 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$149 | 53 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 57 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 60 HOLD |